免疫介导性结肠炎的疾病结果:一项描述初始内镜和组织学表现和治疗选择的研究
Malek Shatila1, Carolina Colli Cruz1, Kei Takigawa2
11Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston TX.
免疫介导性大肠炎 (IMC) 是免疫检查点抑制剂 (ICI) 的毒性日益增加. 这项大型研究详细介绍了IMC的特征,并发现infliximab和vedolizumab在症状缓解方面同样有效,而infliximab提供了更快的反应.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
背景情况:
- 免疫检查点抑制剂 (ICI) 的使用越来越多,导致免疫介导性结肠炎 (IMC) 的增加.
- 之前对IMC的研究受到小样本尺寸的限制.
- 本研究提供了IMC临床,内镜和组织学特征以及治疗结果的全面分析.
研究的目的:
- 描述免疫介导性大肠炎 (IMC) 的临床,内镜和组织学特征.
- 评估IMC治疗方法的疗效.
- 在大量患者队列中提供IMC的全面说明.
主要方法:
- 在2010年至2024年期间接受ICI并发展到IMC的1,151名患者的回顾性分析.
- 数据收集包括人口统计,便生物标志物,内镜和组织学发现,症状,治疗方法和结果.
- 评估的结果包括临床缓解,住院和死亡率.
主要成果:
- 腹 (98.3%) 和腹痛 (38.6%) 是常见的症状.
- 大约46%的患者需要免疫抑制治疗,85%的患者实现了症状缓解.
- 与vedolizumab相比,infliximab的临床反应时间较短,两种治疗方法的整体疗效相似.
结论:
- 这是迄今为止关于免疫媒介性结肠炎 (IMC) 的最大规模研究,详细介绍了其各种表现和治疗反应.
- IMC与其他炎症性胆固醇共享特征.
- 无论是infliximab还是vedolizumab都对IMC缓解有效,但infliximab提供了更快的反应;需要进行更大的研究.
更多相关视频
05:41Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
